Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Sarcoma, Endometrial Stromal

ClinicalTrials.gov lists 22 trials for Sarcoma, Endometrial Stromal or a narrower condition beneath it. European Organisation for Research and Treatment of Cancer - EORTC has the most among industry and government lead sponsors, with 6.

MeSH D018203 Neoplasms Neoplasm C04 C12 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 1 Phase 2 Phase 2 15 Phase 3 Phase 3 4 Observational Observational 1 Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 1 Phase 2 Phase 2 15 Phase 3 Phase 3 4 Observational Observational 1

Trials per phase

22 of the 22 trials are tagged with Sarcoma, Endometrial Stromal itself; the rest are tagged with a narrower condition beneath it.

Get the Sarcoma, Endometrial Stromal report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Sarcoma, Endometrial Stromal trials start? (17)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 3
  • Observational

Top of scale: 3

1992: 1 trials (Observational 1) 1995: 1 trials (Phase 3 1) 1996: 1 trials (Phase 3 1) 1997: 1 trials (Phase 2 1) 1998: 1 trials (Phase 2 1) 2000: 3 trials (Phase 2 2, Phase 1/2 1) 2001: 1 trials (Phase 2 1) 2003: 1 trials (Phase 2 1) 2007: 2 trials (Phase 2 2) 2008: 1 trials (Phase 2 1) 2010: 1 trials (Phase 3 1) 2011: 1 trials (Phase 2 1) 2014: 1 trials (Phase 2 1) 2019: 1 trials (Phase 2 1) 2021: 1 trials (Phase 1 1) 2024: 1 trials (Phase 2 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 1
2024 1
2021 1
2019 1
2014 1
2011 1
2010 1
2008 1
2007 2
2003 1

No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Sarcoma, Endometrial Stromal trials in? (5)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 1/2 1
Phase 2 15
Phase 3 4
Observational 1

How many Sarcoma, Endometrial Stromal trials are recruiting? (4)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 2
Completed 18
Terminated 1
Unknown status 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Sarcoma, Endometrial Stromal trials? (6)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
European Organisation for Research and Treatment of Cancer - EORTC 6
Gynecologic Oncology Group 3
Novartis Pharmaceuticals 2
HRYZ Biotech Co. 1
NCIC Clinical Trials Group 1

Which drugs are being tested for Sarcoma, Endometrial Stromal? (1)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
Imatinib 2

Interventions as named in the registry (14)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Ifosfamid 3
Doxorubicine 3
Pegylated Liposomal Doxorubicin (PLD), Doxil 2
Filgrastime (G-CSF) 2
Radiation Therapy 2

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which serious adverse events do Sarcoma, Endometrial Stromal trials report? (10)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Abdominal Pain 4 1
Adrenal Adenoma 3 1
Death Nos 3 1
Anemia 2 1
Death not associated with CTCAE term-Disease progression NOS 2 1

Which publications cover Sarcoma, Endometrial Stromal? (26)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113). International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020 Yes
Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2019 Yes
Endometrial stromal tumours revisited: an update based on the 2014 WHO classification. Journal of clinical pathology 2015 Yes
Fertility-sparing management combined with photodynamic therapy for endometrial stromal sarcoma: a case report. Photodiagnosis and photodynamic therapy 2014 Yes
Endometrial stromal tumors: the new WHO classification. Advances in anatomic pathology 2014 Yes

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Endometrial stromal sarcoma 213711 Exact Orphadata Science knowledge files, Product 1
Endometrial stromal sarcoma 213711 Exact Orphanet Rare Disease Ontology (ORDO)

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: prevalence and sub-conditions in mesh.

Browse all condition evidence pages